Praxair (PX) Misses Q2 EPS by 1c; FY15 EPS Outlook Trimmed

Praxair (NYSE: PX) reported Q2 EPS of $1.45, $0.01 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.85 billion.

Praxair sees FY2015 EPS of $5.80-$5.95, versus prior guidance of $5.90-$6.15 and the consensus of $5.99.

For earnings history and earnings-related data on Praxair (PX) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04